Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats

Oxidative Medicine and Cellular Longevity

Volumn 2, Issue 5, 2009, Pages 328-334

  Baynes, John ^a   Murray, David B ^b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Cardiomyopathy; Diabetes; Hydronephrosis

Indexed keywords

ALBUMIN; CREATININE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CATHETER; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLE; DISEASE COURSE; DISEASE SEVERITY; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HYDRONEPHROSIS; KIDNEY FUNCTION; KIDNEY MASS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEINURIA; RAT; SYSTOLE; URINE LEVEL; ZUCKER DIABETIC FATTY RAT;

AGING; ALBUMINURIA; ANIMALS; CARDIOMYOPATHIES; CREATININE; DIABETES MELLITUS, TYPE 2; KIDNEY; KIDNEY FUNCTION TESTS; RATS; RATS, ZUCKER;

ANIMALIA; RATTUS;

EID: 77953435480     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.2.5.9831     Document Type: Article

References (50)

1. Dagenais GR, Gerstein HC, Holman R, et al. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes Care 2008; 31:1007-14.
2. Maione A, Nicolucci A, Craig JC, et al. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial. J Nephrol 2007; 20:646-55.
3. McQueen MJ, Lonn E, Gerstein HC, Bosch J, Yusuf S. The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences. Scand J Clin Lab Invest Suppl 2005; 240:143-56.
4. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34:29-34.
5. Mainous AG, III, Baker R, Koopman RJ, et al. Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way. Diabetologia 2007; 50:934-40.
6. Department of Health and Human Services CfDCaP. National Diabetes Fact Sheet 2007, www.cdc.gov. Diabetes Data and Trends 2009.
7. American Diabetes Association. National Diabetes Fact Sheet, 2002. Accessed online at http://www.diabetes.org/diabetesstatistics/national-diabetic- fact-sheet.jsp. 2006.
8. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115:3213-23.
9. El-Atat FA, Stas SN, McFarlane SI, Sowers JR. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004; 15:2816-27.
10. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116:85-97.
11. Gilbert RE, Connelly K, Kelly DJ, Pollock CA, Krum H. Heart failure and nephropathy: catastrophic and interrelated complications of diabetes. Clin J Am Soc Nephrol 2006; 1:193-208.
12. Marsh SA, Powell PC, Agarwal A, Dell'Italia LJ, Chatham JC. Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis. Am J Physiol Heart Circ Physiol 2007; 293:292-8.
13. Schafer S, Linz W, Bube A, et al. Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats. Cardiovasc Res 2003; 60:447-54.
14. Wang P, Lloyd SG, Zeng H, Bonen A, Chatham JC. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 2005; 288:2102-10.
15. Yue TL, Bao W, Gu JL, et al. Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/ reperfusion-induced myocardial injury. Diabetes 2005; 54:554-62.
16. Schafer S, Huber J, Wihler C, Rutten H, Busch AE, Linz W. Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine. Eur J Heart Fail 2006; 8:2-6.
17. Janiak P, Bidouard JP, Cadrouvele C, et al. Longterm blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. Eur J Pharmacol 2006; 534:271-9.
18. Chander PN, Gealekman O, Brodsky SV, et al. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 2004; 15:2391-403.
19. Weisfeldt ML, Scully HE, Frederiksen J, Rubenstein JJ, Pohost GM, Beirholm E, et al. Hemodynamic determinants of maximum negative dP/dt and periods of diastole. Am J Physiol 1974; 227:613-21.
20. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976; 58:751-60.
21. De Vriese AS, Stoenoiu MS, Elger M, et al. Diabetesinduced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide. Kidney Int 2001; 60:202-10.
22. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 2005; 26:11-7.
23. Fredersdorf S, Thumann C, Ulucan C, et al. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol 2004; 13:11-9.
24. Suzaki Y, Ozawa Y, Kobori H. Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int J Biol Sci 2007; 3:40-6.
25. Siddiqui AH, Ali Q, Hussain T. Protective role of angiotensin II subtype 2 receptor in blood pressure increase in obese Zucker rats. Hypertension 2009; 53:256-61.
26. Janicki JS, Brower GL, Gardner JD, et al. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res 2006; 69:657-65.
27. Damman K, Navis G, Smilde TD, et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007; 9:872-8.
28. Ritz E. Left ventricular hypertrophy in renal disease: beyond preload and afterload. Kidney Int 2009; 75:771-3.
29. Ramchandra R, Hood SG, Frithiof R, May CN. Discharge properties of cardiac and renal sympathetic nerves and the impaired control of blood volume in heart failure. Am J Physiol Regul Integr Comp Physiol 2009.
30. Carabello BA. Concentric versus eccentric remodeling. J Card Fail 2002; 8:258-63.
31. Janicki JS, Brower GL, Gardner JD, Chancey AL, Stewart JA Jr. The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling. Heart Fail Rev 2004; 9:33-42.
32. Dawson A, Morris AD, Struthers AD. The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia 2005; 48:1971-9.
33. Salmasi AM, Rawlins S, Dancy M. Left ventricular hypertrophy and preclinical impaired glucose tolerance and diabetes mellitus contribute to abnormal left ventricular diastolic function in hypertensive patients. Blood Press Monit 2005; 10:231-8.
34. Sato A, Tarnow L, Nielsen FS, Knudsen E, Parving HH. Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment. QJM 2005; 98:879-84.
35. Dominguez JH, Wu P, Hawes JW, et al. Renal injury: similarities and differences in male and female rats with the metabolic syndrome. Kidney Int 2006; 69:1969-76.
36. Coimbra TM, Janssen U, Grone HJ, et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57:167-82.
37. Etgen GJ, Oldham BA. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 2000; 49:684-8.
38. Bickel CA, Verbalis JG, Knepper MA, Ecelbarger CA. Increased renal Na-K-ATPase NCC, and beta-ENaC abundance in obese Zucker rats. Am J Physiol Renal Physiol 2001; 281:639-48.
39. Bickel CA, Knepper MA, Verbalis JG, Ecelbarger CA. Dysregulation of renal salt and water transport proteins in diabetic Zucker rats. Kidney Int 2002; 61:2099-110.
40. Maddox DA, Alavi FK, Silbernick EM, Zawada ET. Protective effects of a soy diet in preventing obesitylinked renal disease. Kidney Int 2002; 61:96-104.
41. Vora JP, Zimsen SM, Houghton DC, Anderson S. Evolution of metabolic and renal changes in the ZDF/ Drt-fa rat model of type II diabetes. J Am Soc Nephrol 1996; 7:113-7.
42. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008; 205:2409-17.
43. Ninomiya H, Inomata T, Ogihara K. Microvasculature of hydronephrotic kidneys in KK-A(Y) mice. J Vet Med Sci 2000; 62:1093-8.
44. Mundet X, Pou A, Piquer N, et al. Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain. Prim Care Diabetes 2008; 2:135-40.
45. Joseph J, Koka M, Aronow WS. Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke or congestive heart failure in an academic nursing home. J Am Med Dir Assoc 2008; 9:257-9.
46. Wang P, Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 2004; 286:725-36.
47. Leehey DJ, Singh AK, Alavi N, Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl 2000; 77:93-8.
48. Murray DB, Gardner JD, Brower GL, Janicki JS. Effects of Non-Selective Endothelin-1 Receptor Antagonism on Cardiac Mast Cell-Mediated Ventricular Remodeling in Rats. Am J Physiol Heart Circ Physiol 2008.
49. Wei CL, Valvano JW, Feldman MD, Nahrendorf M, Peshock R, Pearce JA. Volume catheter parallel conductance varies between end-systole and end-diastole. IEEE Trans Biomed Eng 2007; 54:1480-9.
50. Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 2008; 3:1422-34.